CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses (Q60649734)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18651710%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18651710%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18651710%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Sonya James

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18651710%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Fernanda V V Castro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18651710%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Alison L Tutt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18651710%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Ann L White

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18651710%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Ruth R French

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18651710%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Martin J Glennie

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18651710%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

English

0 references

publication date

1 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18651710%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18651710%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18651710%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18651710%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

2263-2273

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18651710%20AND%20SRC:MED&resulttype=core&format=json

Dendritic cells and the control of immunity

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Tolerogenic dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Exploiting lymphatic transport and complement activation in nanoparticle vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Receptor-mediated delivery of antigens to dendritic cells: anticancer applications

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Aldehyde-mannan antigen complexes target the MHC class I antigen-presentation pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Antigen delivery via two molecules on the CD8- dendritic cell subset induces humoral immunity in the absence of conventional "danger".

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Differential antigen processing by dendritic cell subsets in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Mouse and human dendritic cell subtypes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Cutting Edge: Intravenous Soluble Antigen Is Presented to CD4 T Cells by CD8- Dendritic Cells, but Cross-Presented to CD8 T Cells by CD8+ Dendritic Cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Distinct dendritic cell subsets differentially regulate the class of immune response in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

The beta2 integrin CD11c distinguishes a subset of cytotoxic pulmonary T cells with potent antiviral effects in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

The leukocyte integrins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Rapid Monoclonal Antibody Generation Via Dendritic Cell TargetingIn Vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Clinical trials of bispecific antibody MDX-210 in women with advanced breast or ovarian cancer that overexpresses HER-2/neu

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Cross-presentation, dendritic cells, tolerance and immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

CD8alpha+ dendritic cells are required for efficient entry of Listeria monocytogenes into the spleen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Antigen transmission by replicating antigen-bearing dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. II. Expression in situ in lymphoid and nonlymphoid tissues

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Protein-specific helper T-lymphocyte formation initiated by dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Lymphokine enhances the expression and synthesis of Ia antigens on cultured mouse peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Introduction of soluble protein into the class I pathway of antigen processing and presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Bispecific Ab therapy of B-cell lymphoma: target cell specificity of antibody derivatives appears critical in determining therapeutic outcome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838302

7 January 2021

Identifiers

DOI

10.1002/EJI.200838302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18651710%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference